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Changes in chromatin state contribute to the switch in gene expression programs that characterizes
the transition of dividing neural stem cells toward a neuronal fate. In this issue of Neuron, Lessard
et al. show that this process is regulated by specific cofactor exchanges within the SWI/SNF chroma-
tin remodeling complex.In order to develop specialized cell
types and tissues, multicellular organ-
isms depend on epigenetic mecha-
nisms—processes that initiate and
maintain specific gene expression pat-
terns that are passed on to progeny
without altering the DNA sequence. A
wealth of cell-type-specific master
transcription factors that orchestrate
global gene expression patterns during
differentiation is known. However,
transcription of the genes they regulate
is critically dependent on the accessi-
bility of chromatin at these gene loci
by the transcriptional machinery. The
transitions from proliferating neural
stem cells or progenitors toward com-
mitted precursors, and finally, to termi-
nally differentiated cells of the neu-
ronal, astrocytic, or oligodendrocytic
lineage, are subject to extensive epige-
netic control (reviewed in Hsieh and
Gage 2004, 2005), but our understand-
ing of the details of these processes re-
mains sketchy. By carefully examining
the multisubunit, ATP-dependent SWI/
SNF-like chromatin remodeling com-
plex in the developing nervous system,
Lessard et al. (2007), in this issue of
Neuron, now show that the precise
cofactor composition of this complex
determines whether neural stem cells
continue to divide or differentiate.
The cell has two basic tools at its
disposal to dynamically regulate chro-
matin state: covalent modification of
chromatin, which includes histone
modifications such as acetylation and
methylation at specific positions, and
ATP-dependent chromatin remodel-
ing. The latter process is carried out
by enzyme complexes that utilize theenergy released by ATP hydrolysis to
slide or peel away histone octamers
around which nucleosomal DNA is
wrapped, thus exposing the DNA and
facilitating the binding of sequence-
specific transcription factors (reviewed
in de la Serna et al., 2006). Emphasiz-
ing their diverse roles in regulating
gene expression, several families of
chromatin remodelers are known to
date, each with unique compositions
and specialized tasks. Among these,
the best understood chromatin remod-
elers belong to the family of Brahma-
related gene (Brg)/Brahma (Brm)-
associated factor (BAF) complexes,
also known as SWI/SNF complexes.
Like most large enzyme machines,
SWI/SNF complexes are composed
of a set of central subunits that pro-
vides the core enzymatic activity of
the complex, along with several asso-
ciated factors that serve specialized
roles in substrate targeting, recruit-
ment of additional regulatory machin-
ery, or both (Figure 1). What makes
the vertebrate SWI/SNF complex so
special, however, is the fact that its
subunit composition varies according
to cell type, suggesting a functionally
relevant combinatorial assembly
(Olave et al., 2002; Wang et al., 1996).
Since, in neurogenesis, at least, Brg
does not appear to be highly regulated
(Seo et al., 2005), any specialized func-
tion of the complex must therefore be
mediated by the accessory subunits.
Previous work from the Crabtree group
had shown that, indeed, a subset of
BAFs is encoded by families of highly
homologous genes that are differen-
tially expressed across cell types. ForNeuronexample, while BAF53a was found in
all tissues examined (albeit at varying
levels), BAF53b was shown to be ex-
clusively expressed in the adult brain
(Olave et al., 2002). Likewise, BAF60
comes in three flavors (BAF60a, b,
and c), and the expression pattern of
these homologs varies according to
cell type (Wang et al., 1996). These
findings raised the intriguing possibility
that the homologs of individual BAFs
are assembled into the SWI/SNF com-
plex in a mutually exclusive fashion,
allowing for a combinatorial variety of
SWI/SNF complexes with distinct
functions during development and in
the adult.
By demonstrating two functionally
relevant cofactor swaps in the SWI/
SNF complex during the development
of the murine brain, Lessard et al.
(2007) now provide evidence that
SWI/SNF subunit composition can in-
deed regulate cell fate. Biochemical
purification of the SWI/SNF complex
from the brains of newborn mice
yielded, in addition to almost all previ-
ously known BAFs, four more homolo-
gous proteins, termed BAF45a, b, c,
and d. Examination of the expression
patterns of BAF45 and BAF53 ho-
mologs during brain development
revealed a rather tight switch: just
around embryonic day 12–13 (E12–
13), BAF45a and BAF53a give way to
BAF45b/c and BAF53b, respectively.
This is around the same time that
neural stem/progenitor cells in the
developing brain cease to proliferate
and start to differentiate into neurons.
Indeed, immunofluorescence staining
for these BAFs in E12.5 spinal cords55, July 19, 2007 ª2007 Elsevier Inc. 171
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expression patterns, with
BAF45a and BAF53a con-
fined to proliferative regions,
and BAF45b/c and BAF53b
mainly expressed in the dif-
ferentiated zone.
So, these data strongly
suggested the existence of
two distinct SWI/SNF com-
plexes during development:
a neural progenitor-specific
complex, termed npBAF,
and the postmitotic neuron-
specific complex, nBAF
(Figure 1). But do these com-
plexes indeed function dif-
ferently? To investigate this,
Lessard et al. (2007) em-
ployed a whole battery of
in vivo and in vitro experi-
ments. Consistent with a
critical role for npBAF com-
plexes in maintaining neural
stem/progenitor cells in
a proliferative state, neural-
specific BAF45a gain of
function led to an increase
in the mitotic index of cells
both in vivo and in cell cul-
ture, while BAF45a loss of
function, BAF53a loss of
function, or both reduced
the cell proliferation rate in
cultured cells without affecting the
survival or extent of neuronal differenti-
ation. Lessard et al. (2007) further sub-
stantiated these findings by crossing
mice expressing Cre recombinase
driven by the Nestin promoter with
mice carrying a single Brg allele flanked
byLoxPsites. Since the promoterof the
Nestin gene is activated around E10.5,
i.e., just prior to the time when the
switch from npBAF complexes to
nBAF complexes occurs, the progeny
of this cross lose Brg expression before
the nBAF stage. This technique thereby
provided a tool to study the role of Brg
in proliferating neural stem/progenitor
cells. In contrast to a constitutive
knockout of Brg, which results in peri-
implantation lethality (Bultman et al.,
2000), Nestin-Cre/Brg-floxed fetuses
develop to term but are born without
respiration and have drastically smaller
brains, as well as other brain defects of
varying severity.
These findings highlight the impor-
tance of npBAF complexes in keeping
neural stem/progenitor cells in a prolif-
erative state. In the absence of Brg,
npBAF complexes are catalytically
inactive, and may not even assemble
into a stable complex. Reduced cell
proliferation may then deplete the pool
of stem/progenitor cells necessary for
proper brain development. In support
of this notion, cortical cultures and neu-
rospheres prepared from these Brg-
deficient embryos showed reduced
mitotic index and self-renewal capac-
ity, respectively (Lessard et al., 2007).
Hints as to what signaling pathways
might be regulated by npBAF com-
plexes come from transcript array
analyses of telencephalons of npBAF
loss-of function mice. Here, several
components of signaling pathways
and transcription factors previously
implicated in neural stem cell mainte-
nance, such as proteins functioning in
the Sonic Hedgehog (SHH)
and Notch pathways, show
aberrant expression levels.
Most of these perturbations
in gene expression levels
probably arose secondarily,
via dysregulation of proteins
that regulate them. How-
ever, Lessard et al. (2007)
show by chromatin immu-
noprecipitation (ChIP) that
BAF45a and BAF53a are in-
deed associated with the
promoters of a subset of
these genes, thus providing
evidence for direct gene
regulation by npBAF com-
plexes. Obviously, npBAF
and nBAF complexes bind
and regulate many more
gene targets. With recent
advances in high-through-
put sequencing technology,
it is now feasible to address
promoteroccupancyonage-
nome-wide scale (Johnson
et al., 2007). Further expres-
sion analysis at lociof interest
would then reveal down-
stream candidate genes
differentially regulated by
npBAF complexes versus
nBAF complexes.
These findings clearly
show that BAF complexes exert their
effect on cell proliferation and differen-
tiation by producing substantial
changes in gene expression programs
in a chromatin-dependent manner.
However, they do not give any clues
as to the molecular mechanisms
involved. How can a rather subtle
change in cofactor composition of
the SWI/SNF complex lead to global
changes in transcriptional output?
While several core components of the
SWI/SNF complex have intrinsic chro-
matin binding activity, the core com-
plex does not bind DNA in a se-
quence-specific manner. Thus, SWI/
SNF complexes are often targeted
to promoters by other transcriptional
machinery. This dependence on re-
cruiters, therefore, may impart pro-
moter specificity. For example, it was
found that BAF57 binds to the CoREST
corepressor, and this interaction was
proposed to recruit the SWI/SNF
Figure 1. Regulation of Neurogenesis by Differentially
Assembled BAF Complexes
BAF chromatin remodeling complexes, also known as SWI/SNF com-
plexes, are comprised of a catalytic subunit (Brg/Brm) and additional
core subunits, including BAF250, BAF170, BAF155, BAF60, BAF57,
BAF47, and actin. Neural progenitor-specific BAF (npBAF) complexes
contain two additional subunits, BAF45a and BAF53a (in red). During
neuronal differentiation, these are exchanged for neuron-specific
homologous proteins, BAF45b/c, and BAF53b (in green), thus forming
postmitotic neuron-specific BAF (nBAF) complexes. While npBAF
complexes specify gene expression patterns necessary for neural
stem/progenitor cell proliferation, the switch in cofactor composition
is critical for neuronal differentiation. Figure credit: Jamie Simon.172 Neuron 55, July 19, 2007 ª2007 Elsevier Inc.
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a binding site for the NSRF/REST tran-
scriptional repressor complex (Batta-
glioli et al., 2002; Ooi et al., 2006). Sim-
ilarly, BAF45a and BAF53a on the one
hand, and BAF45b/c and BAF53b on
the other, might differentially mediate
recruitment of SWI/SNF to genes via
promoter-bound complexes. Support
for this notion comes from the finding
that despite the large overall homology
between BAF45 homologs, it is the
most divergent domains of BAF45a
that are necessary for its positive
effect on cell proliferation (Lessard
et al., 2007).
Alternatively, the BAFs might act
to block binding of the SWI/SNF com-
plex to promoter-bound transcription
factors. Such a mechanism has been
proposed for Geminin (Gem), a key
regulator of cell cycle progression
that has also been shown to directly
compete with Brg for binding to pro-
neural transcription factors, including
neurogenin and NeuroD, thus prevent-
ing SWI/SNF-mediated transcriptional
activation of their target genes in pro-
genitor cells (Seo et al., 2005). As cells
differentiate toward the neuronal line-
age, Gem is downregulated and the
Gem-mediated block of transcription
factor activation is relieved. Surpris-
ingly, Gem was not recovered in the
biochemical approach employed by
Lessard et al. (2007). This discrepancy
requires further investigation. How-
ever, the Gem-Brg interaction was ini-
tially identified in a yeast two-hybrid
screen, and it is possible that it is not
robust enough to survive the high-stringency purification procedure
employed by Lessard et al. (2007).
From an epigenetic perspective, the
findings in this paper may further our
understanding of how different types
of epigenetic processes are mechanis-
tically linked. It is well known that SWI/
SNF complexes associate with chro-
matin modifications, such as acety-
lated histones. Intriguingly, recent
work has shown that the PHD finger
domain of the nucleosome remodeling
factor (NURF), another ATP-depen-
dentchromatin remodeler,bindsaspe-
cific histone methylation (Wysocka
et al., 2006). If the PHD domains found
in the novel BAF45 homologs also bind
methylated histones, BAF45-contain-
ing SWI/SNF complexes will instantly
provide biologically well-defined plat-
forms to analyze the coordinated
action of different epigenetic mecha-
nisms. Analysis of histone modifica-
tions at gene loci identified by ChIP-
based studies of BAF components
may lead to a better mechanistic un-
derstanding of the underlying cohort
of epigenetic mechanisms.
In the past few years, much attention
has been devoted to the ever-growing
body of known histone modifications
involved in transcriptional control.
This ‘‘histone code’’ (Jenuwein and
Allis, 2001) has been suggested to
direct diverse chromatin states in
a manner dependent on the com-
bination of modifications present at
a gene locus. The work by Lessard
et al. (2007) now suggests that
combinatorially assembled chromatin
remodelers could act in an equallyNeuron 5complex manner to specify transcrip-
tional activity.
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